TRI Launches TRIAL.OS for Clinical Trial Management

Oct 13, 2026
TRIAL.OS provides AI assisted applications for clinical trial analysis, risk identification and recommended actions.

Triumph Research Intelligence, known as TRI, announced in a press release the launch of TRIAL.OS, an operating system of AI assisted applications for clinical trials. TRI says TRIAL.OS is being built around six functions: understand, predict, explain, recommend, automate and learn, with the aim of telling study teams where the risks in a trial are, why, and what to do about them.

Customers can use individual applications, access them through TRI's OPRA risk based quality management platform, or run them alongside existing systems. TRI says organizations can test TRIAL.OS with their own clinical trial protocol or a synthetic protocol matched to their therapy area.

TRI plans to add capabilities each month. The company says TRIAL.OS is developed under the same quality management system as OPRA and in line with ICH E6(R3), 21 CFR Part 11, Good Clinical Practice and GDPR. Every output is a draft that the study team reviews and owns, under an AI framework covering human oversight and EU AI Act alignment.

We hope you enjoyed this article

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)
Free newsletter

Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Whitepaper

Tensordyne Napier: What If One Rack Could Do the Work of Nine?

Tensordyne

This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.

Read more

You may also like

Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.